Skip to content

Upcoming FDA PDUFA Date For Exelisis’ Orphan Drug Cabozantinib Creates Viral Internet Information Sensation

November 27, 2012

       On November 26, 2012, the Orphan Druganaut Blog, reports that CafePharma.com, a website for pharmaceutical and medical sales professionals, has a “Social Media Monitoring Page for Exelixis” reporting the following statistics :  

–          # of Twitter tweets in the last 24 hours = 49 

–          Average Twitter tweets per    24 hours =   6.  

        One day later, November 27, 2012, at approximately 11:15 AM EST, CafePharma.com’s “Social Media Monitoring Page for Exelixis” reports the following statistics : 

–          # of Twitter tweets in the last 24 hours = 85 

–          Average Twitter tweets per    24 hours =   11.  

       SeekingAlpha.com’s November 27, 2012 article titled, “Exelixis Traders Brace For Upcoming FDA Decision” reviews the question of whether or not Exelisis’ orphan drug Cabozantinib will receive FDA approval for Medullary Thyroid Cancer on November 29, 2012. 

Additional Background Information 

Cabozantinib Clinical Trial Information  

OncLive.com article titled, “Cabozantinib Submitted for FDA Approval After Positive Phase III Thyroid Cancer Trial”  

YouTube.com Video titled, “Dr. Ezra Cohen Discusses The Cabozantinib EXAM Trial”   

Copyright © 2012-2013, Orphan Druganaut Blog.  All rights reserved.

Advertisements
Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: